• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Catalog Number JHJR080502J
Device Problem Complete Blockage (1094)
Patient Problem Occlusion (1984)
Event Date 06/11/2020
Event Type  Injury  
Manufacturer Narrative
Review of the manufacturing records could not be completed as no lot number information was provided.The device was not returned.Consequently, a direct product analysis was not possible.All information has been placed on file for use in tracking and trending.A response letter was not requested.
 
Event Description
The following was reported to gore: on an unknown date, a gore® acuseal vascular graft (acuseal) was implanted as an arteriovenous graft.On (b)(6) 2020, a gore® viabahn® endoprosthesis with heparin bioactive surface (viabahn) was additionally implanted to treat occlusion at the venous anastomosis of the acuseal.On june 11, 2020, it was reported that the viabahn was occluded.On the same day, thrombectomy using a balloon catheter was performed to treat the occlusion, and blood flow was recovered.After that, platelet count was decreased, and it was revealed that heparin-induced thrombocytopenia (hit) antibody was positive.Therefore, heparin was discontinued and argatroban was administered.Platelet count was recovering.
 
Manufacturer Narrative
Additional manufacturing narrative: c1.Name (#1) - cbas® heparin surface; manufacturer/compounder: w.L.Gore & associates, inc.Lot #17842998.Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Manufacturer Narrative
Additional manufacturer narrative: b6.- relevant tests/laboratory data, including dates.
 
Manufacturer Narrative
Corrected data: h6.- method code 1.H6.- results code 1.Additional manufacturer narrative: review of the manufacturing records verified that the lot met release requirements.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key10222109
MDR Text Key197964382
Report Number2017233-2020-00461
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup,Followup
Report Date 07/30/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/01/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/14/2021
Device Catalogue NumberJHJR080502J
Device Lot Number17842998
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age58 YR
Patient Weight75
-
-